Institutions / NEA Management Company, LLC
NEA Management Company, LLC
CIK 1512848 · Institution · as of Dec 31, 2025
Portfolio value
$1.96B
Positions
27
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 27 →
| Company | Value | % of portfolio |
|---|---|---|
| Celcuity Inc.CELC | $352.64M | 18.0% |
| Rhythm Pharmaceuticals, Inc. | $311.48M | 15.9% |
| Arcellx, Inc. | $198.55M | 10.1% |
| Trevi Therapeutics, Inc. | $165.54M | 8.4% |
| Savara IncSVRA | $147.56M | 7.5% |
| Zenas BioPharma, Inc.ZBIO | $127.93M | 6.5% |
| Monte Rosa Therapeutics, Inc. | $120.62M | 6.2% |
| MBX Biosciences, Inc.MBX | $114.00M | 5.8% |
| Coursera, Inc. | $94.71M | 4.8% |
| Aurinia Pharmaceuticals Inc.AUPH | $63.32M | 3.2% |
| Gossamer Bio, Inc. | $56.09M | 2.9% |
| CRISPR Therapeutics AG | $55.51M | 2.8% |
| Oric Pharmaceuticals, Inc. | $33.69M | 1.7% |
| Phathom Pharmaceuticals, Inc.PHAT | $32.52M | 1.7% |
| CVRx, Inc.CVRX | $14.39M | 0.7% |
| X4 Pharmaceuticals, Inc. | $12.93M | 0.7% |
| Champions Oncology, Inc.CSBR | $11.84M | 0.6% |
| Black Diamond Therapeutics, Inc.BDTX | $10.81M | 0.6% |
| Korro Bio, Inc. | $8.74M | 0.4% |
| Inventiva SA | $6.80M | 0.3% |
| Nkarta, Inc.NKTX | $6.60M | 0.3% |
| Senti Biosciences, Inc. | $3.93M | 0.2% |
| LeonaBio, Inc.LONA | $3.52M | 0.2% |
| Synlogic, Inc. | $3.27M | 0.2% |
| Marker Therapeutics, Inc. | $2.42M | 0.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.